2 Reasons to avoid UFPT and 1 stock to buy instead
Q2 Earnings Roundup: UFP Technologies (NASDAQ:UFPT) And The Rest Of The Drug Development Inputs & Services Segment
UFP Technologies (UFPT) Stock Looks Rich Despite Its 378% Five Year Run
Labor Problems Pressured UFP Technologies (UFPT)
Implied Volatility Surging for UFP Technologies Stock Options
UFP Technologies (UFPT) Posts Record Profits, But The Margin Story Gets Complicated
UFP Technologies Director Cynthia Feldmann Sells 1,000 Shares
UFP Technologies Targets 12%-18% Growth as Medical Device M&A Pipeline Builds
Insider Unloading: Marc D Kozin Sells $2.13M Worth Of UFP Technologies Shares
UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the 17th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL
Options Exercise: Symeria Hudson At UFP Technologies Realizes $137K
The Top 5 Analyst Questions From UFP Technologies’s Q2 Earnings Call
UFP Technologies Executive Chairman Sold $5.00M In Company Stock
UFP Technologies (UFPT) Q2 2026 Earnings Call Transcript
UFP Technologies (UFPT) Could Be 8% Below Fair Value After Record Q2 Results
UFP Technologies Q2 Earnings Call Highlights
UFP Technologies, Inc. Q2 2026 Earnings Call Summary
UFP Technologies, Inc. (UFPT) Q2 2026 Earnings Call Transcript
UFP Technologies Reports Q2 2026 Results: Full Earnings Call Transcript
UFP Technologies (UFPT) Beats Q2 Earnings and Revenue Estimates
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.